Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03171545 · ClinicalTrials.gov registry record · NA
Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 1,431
- Enrollment target
NCT03171545 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 1,431 participants.
The verdict
NCT03171545, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,431 participants
- Enrollment target
Study Summary
The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.
Interventions
- BEHAVIORAL Provider Education
- BEHAVIORAL Patient Activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,431 participants |
| Start Date | 2023-01-11 |
| Est. Completion | 2024-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03171545
The ClinicalTrials.gov registry entry for NCT03171545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,431 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Provider Education is the first listed.
NCT03171545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03171545 about?
NCT03171545 is a clinical study titled "Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)". The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.
What is the current status of trial NCT03171545?
This trial is currently completed. It is a NA study. The enrollment target is 1,431 participants. The study started on 2023-01-11. Estimated completion is 2024-12-13.
What interventions are being tested in trial NCT03171545?
The interventions under investigation include: Provider Education (BEHAVIORAL), Patient Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03171545?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.